Impact of Commercialized Genomic Tests on Adjuvant Treatment Decisions in Early Stage Breast Cancer Patients

Table 1

Baseline characteristics of the patient.

Characteristics	Patients
Age (years), mean	51.67 (31–81)
Primary surgery, n(%)
Total mastectomy	25 (33.33)
Partial mastectomy	50 (67.67)
Histology, n (%)
Invasive ductal carcinoma	63 (84.00)
Invasive lobular carcinoma	12 (16.00)
Presence of DCIS, n (%)
No	30 (40.00)
Yes	45 (60.00)
Tumor grade, n (%)
Low grade	62 (84.93)
High grade	11 (15.06)
Tumor size, n (%)
<2 cm	44 (59.46)
2–5 cm	30 (40.54)
Ki-67
<14	35 (49.30)
>14	36 (50.70)
Oncotype, n
<18	21
18–31	26
>31	3
Endopredict, n
Low	10
High	4
Prosigna, n
Low	3
Intermediate	7
High	1